Low-grade inflammation in young adults exposed to intrauterine hyperglycemia

Diabetes Research and Clinical Practice

Volumn 97, Issue 2, 2012, Pages 322-330

  Kelstrup, Louise ^a,b   Clausen, Tine Dalsgaard ^b   Mathiesen, Elisabeth R ^a,d   Hansen, Torben ^c   Damm, Peter ^b,d  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Gestational diabetes; Inflammatory markers; Intrauterine hyperglycemia; Intrauterine programming; Long term consequences

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTRAUTERINE HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MATERNAL OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PRENATAL DISORDER; PRENATAL EXPOSURE; PROTEIN BLOOD LEVEL; RISK FACTOR; UPREGULATION;

ADOLESCENT; ADULT; ADULT CHILDREN; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DENMARK; DIABETES MELLITUS, TYPE 1; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INTERLEUKIN-6; MALE; OVERWEIGHT; PREGNANCY; RISK FACTORS; YOUNG ADULT;

EID: 84865187649     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.04.023     Document Type: Article

References (42)

1. Gillman M.W. Developmental origins of health and disease. N Engl J Med 2005, 353(October (17)):1848-1850.
2. Simeoni U., Barker D.J. Offspring of diabetic pregnancy: long-term outcomes. Semin Fetal Neonatal Med 2009, 14(April (2)):119-124.
3. Crowther C.A., Hiller J.E., Moss J.R., McPhee A.J., Jeffries W.S., Robinson J.S. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005, 352(June (24)):2477-2486.
4. Jensen D.M., Korsholm L., Ovesen P., Beck-Nielsen H., Moelsted-Pedersen L., Westergaard J.G., et al. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 2009, 32(June (6)):1046-1048.
5. Clausen T.D., Mathiesen E.R., Hansen T., Pedersen O., Jensen D.M., Lauenborg J., et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008, 31(February (2)):340-346.
6. Clausen T.D., Mathiesen E.R., Hansen T., Pedersen O., Jensen D.M., Lauenborg J., et al. Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab 2009, 94(July (7)):2464-2470.
7. Dabelea D., Hanson R.L., Lindsay R.S., Pettitt D.J., Imperatore G., Gabir M.M., et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 2000, 49(December (12)):2208-2211.
8. Dabelea D. The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care 2007, 30(July (Suppl. 2)):S169-S174.
9. Lawlor D.A., Lichtenstein P., Langstrom N. Association of maternal diabetes mellitus in pregnancy with offspring adiposity into early adulthood: sibling study in a prospective cohort of 280,866 men from 248,293 families. Circulation 2011, 123(January (3)):258-265.
10. Bruce K.D., Byrne C.D. The metabolic syndrome: common origins of a multifactorial disorder. Postgrad Med J 2009, 85(November (1009)):614-621.
11. Meas T. Fetal origins of insulin resistance and the metabolic syndrome: a key role for adipose tissue?. Diabetes Metab 2010, 36(February (1)):11-20.
12. Duncan B.B., Schmidt M.I., Pankow J.S., Ballantyne C.M., Couper D., Vigo A., et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003, 52(July (7)):1799-1805.
13. Freeman D.J., Norrie J., Caslake M.J., Gaw A., Ford I., Lowe G.D., et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002, 51(May (5)):1596-1600.
14. Pradhan A. Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. Nutr Rev 2007, 65(December (12 Pt 2)):S152-S156.
15. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286(July (3)):327-334.
16. Schmidt M.I., Duncan B.B., Sharrett A.R., Lindberg G., Savage P.J., Offenbacher S., et al. Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study. Lancet 1999, 353(May (9165)):1649-1652.
17. Thorand B., Lowel H., Schneider A., Kolb H., Meisinger C., Frohlich M., et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. Arch Intern Med 2003, 163(January (1)):93-99.
18. Guttorm E. Practical screening for diabetes mellitus in pregnant women. Acta Endocrinol Suppl (Copenh) 1974, January (182):11-24.
19. Jensen D.M., Molsted-Pedersen L., Beck-Nielsen H., Westergaard J.G., Ovesen P., Damm P. Screening for gestational diabetes mellitus by a model based on risk indicators: a prospective study. Am J Obstet Gynecol 2003, 189(November (5)):1383-1388.
20. Kuhl C. Glucose metabolism during and after pregnancy in normal and gestational diabetic women. 1. Influence of normal pregnancy on serum glucose and insulin concentration during basal fasting conditions and after a challenge with glucose. Acta Endocrinol (Copenh) 1975, 79(August (4)):709-719.
21. Damm P., Kuhl C., Bertelsen A., Molsted-Pedersen L. Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol 1992, 167(September (3)):607-616.
22. Damm P. Gestational diabetes mellitus and subsequent development of overt diabetes mellitus. Dan Med Bull 1998, 45(November (5)):495-509.
23. Marsal K., Persson P.H., Larsen T., Lilja H., Selbing A., Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996, 85(July (7)):843-848.
24. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15(July (7)):539-553.
25. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23(May (5)):469-480.
26. Christensen U., Lund R., Damsgaard M.T., Holstein B.E., Ditlevsen S., Diderichsen F., et al. Cynical hostility, socioeconomic position, health behaviors, and symptom load: a cross-sectional analysis in a Danish population-based study. Psychosom Med 2004, 66(July (4)):572-577.
27. Timpson N.J., Lawlor D.A., Harbord R.M., Gaunt T.R., Day I.N., Palmer L.J., et al. C-reactive protein and its role in metabolic syndrome: Mendelian randomisation study. Lancet 2005, 366(December (9501)):1954-1959.
28. Timpson N.J., Nordestgaard B.G., Harbord R.M., Zacho J., Frayling T.M., Tybjaerg-Hansen A., et al. C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes (Lond) 2011, 35(February (2)):300-308.
29. Wensley F., Gao P., Burgess S., Kaptoge S., Di A.E., Shah T., et al. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ 2011, 342:d548.
30. Bochud M., Marquant F., Marques-Vidal P.M., Vollenweider P., Beckmann J.S., Mooser V., et al. Association between C-reactive protein and adiposity in women. J Clin Endocrinol Metab 2009, 94(October (10)):3969-3977.
31. Lakoski S.G., Cushman M., Criqui M., Rundek T., Blumenthal R.S., D'Agostino R.B., et al. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J 2006, 152(September (3)):593-598.
32. Saltevo J., Vanhala M., Kautiainen H., Kumpusalo E., Laakso M. Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study. Diabet Med 2008, 25(June (6)):747-750.
33. Thorand B., Baumert J., Kolb H., Meisinger C., Chambless L., Koenig W., et al. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 2007, 30(April (4)):854-860.
34. Lindegaard M.L., Svarrer E.M., Damm P., Mathiesen E.R., Nielsen L.B. Increased LDL cholesterol and CRP in infants of mothers with type 1 diabetes. Diabetes Metab Res Rev 2008, 24(September (6)):465-471.
35. Nelson S.M., Sattar N., Freeman D.J., Walker J.D., Lindsay R.S. Inflammation and endothelial activation is evident at birth in offspring of mothers with type 1 diabetes. Diabetes 2007, 56(November (11)):2697-2704.
36. Cross J.A., Temple R.C., Hughes J.C., Dozio N.C., Brennan C., Stanley K., et al. Cord blood telomere length, telomerase activity and inflammatory markers in pregnancies in women with diabetes or gestational diabetes. Diabet Med 2010, 27(November (11)):1264-1270.
37. Cross J.A., Brennan C., Gray T., Temple R.C., Dozio N., Hughes J.C., et al. Absence of telomere shortening and oxidative DNA damage in the young adult offspring of women with pre-gestational type 1 diabetes. Diabetologia 2009, 52(February (2)):226-234.
38. Ruotsalainen E., Salmenniemi U., Vauhkonen I., Pihlajamaki J., Punnonen K., Kainulainen S., et al. Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects. Diabetes Care 2006, 29(December (12)):2714-2720.
39. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102(July (1)):42-47.
40. Spranger J., Kroke A., Mohlig M., Hoffmann K., Bergmann M.M., Ristow M., et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003, 52(March (3)):812-817.
41. Malcolm J.C., Lawson M.L., Gaboury I., Lough G., Keely E. Glucose tolerance of offspring of mother with gestational diabetes mellitus in a low-risk population. Diabet Med 2006, 23(May (5)):565-570.
42. Plagemann A., Harder T., Kohlhoff R., Rohde W., Dorner G. Glucose tolerance and insulin secretion in children of mothers with pregestational IDDM or gestational diabetes. Diabetologia 1997, 40(September (9)):1094-1100.